26 Sep 2019

Breaking through emergent Immunotherapy and Immune targets in Cancer 2019

  • Oncology
  • On-site
  • Spanish
  • Casa Convalescència, Barcelona



Activity finished



Do you want to know the next activities activities on oncology?

Join our newsletter list to be updated on upcoming activities.


The workshop is addressed to medical oncologists, immunologists, basic and translational scientists, clinical researchers, postdoctoral fellows who participate in cancer research, regulatory scientists, as well as other health professionals and pharmaceutical industry personnel who wish to have an overview extensive and detailed of the most recent advances in the field of immunotherapy.

Immunotherapy has meant a breakthrough as a therapy in cancer cure in the last decade. In this regard, there are more and more therapeutic tools that help boost the immune system with the aim of attacking cancer cells. The workshop on “Breaking through emergent immunotherapy and immune targets in cancer” provides a forum for all professionals working in the field of immunotherapy and research in immuno-oncology analyzing the next generation of vaccines, drugs and potential immunotherapeutic procedures to treat cancer.



  • Bonaventura Clotet

    President of the Fight Infections Foundation and Director of the IrsiCaixa AIDS Research Institute

    Fundació Lluita contra les Infeccions, Badalona, Spain. Institut d'Investigació del Sida IrsiCaixa i Institut Català de la Salut, Badalona, Spain.

  • María González Cao

    Medical oncologist

    Dr Rosell Oncology Institute (IOR, Institut Universitari Dexeus, Barcelona)


This activity has been accredited by the Comisión de Formación Continuada del Sistema Nacional de Salud and by the Consell Català de la Formació Continuada de les Professions Sanitàries with 0,8 credits and registered with the num. 09/025744-MD.



    Your Cart
    Your cart is emptyReturn to Shop